Bangladeshi glau­co­ma eye drop man­u­fac­tur­er banned from sup­ply­ing prod­ucts in Eu­rope

Bangladesh-based Bex­im­co Phar­ma­ceu­ti­cals has been pro­hib­it­ed from sup­ply­ing its tim­o­lol and la­tanoprost pre­scrip­tion eye drops for glau­co­ma in the EU and EEA mar­kets on the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER